Objective: Intestinal amebiasis is still an important health problem in developing countries of the world. One of the issues for future biomedical research is the development of antimicrobial resistance, and the search for alternative new antiamoebic drugs. A study was carried out to evaluate the efficacy of albendazole on the viability of Entamoeba histolytica clinical isolate from human which was used for experimental animals. Materials and Methods: All experimental animal models (18 albino mice and 18 rabbits), were divided into 6 groups, each group with either 6 mice or 6 rabbits, were orally infected with E. histolytica (clinical isolate), then after 7 days they were given drugs (Metronidazole or Albendazole) daily according to body weight prepared in advance for 5 days duration and in addition to the controls without drugs. Stool specimens of each group were examined microspically for viable trophozoites, and the number of these trophozoites were counted with haemocytometer chamber, as compared to untreated and treated groups. Statistical analysis was done by using Student's-t-test.
moebiasis is world wide in distribution; it is much more common in the tropics and wherever sanitation is poor, in all climatic zones (1) . It constitutes one of the commonest protozoal infections on a global scale, and it is estimated to infect 10% of the world's population, up to 50 million cases of invasive amebiasis, and about 100,000 deaths and probably represent the third leading parasitic cause of death, behind only malaria and schistosomiasis (2 , 3 ) .
Amoebiasis is treated with metronidazole or one of 5-nitromidazol family of drugs such as tinidazole. Meronidazole is the only drug approved for the treatment of invasive amoebiasis, but it has side effects such as gastric upset, optic atrophy, bitter taste, dermatitis, seizures, and possible carcinogenesi (4) . In addition, treatment failure which is about 20% , raises concern about possible resistance to the used drugs and their use during pregnancy is risky (2) .
Although albendazole is an alternative drug for the treatment of giardiasis (5) , however, as far as we know albendazole experimentally was not tested against E.
histolytica infection. The aim of the present study is to evalute the effectiveness of albendazole as an alternative drug against amoebiasis in experimental animals (mice and rabbits). Feces were diluted in water and sieved with gauze, then antibiotics (penicillin and streptomycin) were added, and cysts were isolated using sucrose gradients. Oral infections were done using about 10 3 -10 4 cysts/ml/ animal (5) .
MATERIALS and METHODS

Mice:
All mice and rabbits were orally infected with 10 3 -10 4 /ml E. histolytica cysts, and equally divided into groups,6 animals for each group which were subjected for treatment with albendazole or metronidazole, and one untreated group was considered as a control one.
Each of the experimentally infected groups was treated with one type of the previously mentioned drugs and was administered orally with the help of a stomach tube through out, and were treated according to the recommended dose (mg/kg body weight/day) for 5 days.
Metronidazol 250 mg/kg three times daily (6) , albendazol 400 mg/kg once daily (5) .
The fecal samples were collected from each group and examined before and after treatment for the detection of the trophozoites or cysts. The effect of drugs was estimated by counting the mean number of viable trophozoites using hemocytometer chamber (2) . before treatment] X 100 (7) .
Results
The results showed no infection was intiated with E. histolytica cyst in all mice used for in this experiment. On the contrary the result showed in all the rabbits used in this experiment infection was induced by E. histolytica cysts . The infection persisted among control group and the cure rate was 0%. The drugs used were effective in the treatment groups with 100% cure rate ( Table 1 ) .
Evaluation of the drug sensitivity for each group
The percentages of trophozoites viability were nearly similar (22.7 and 25%) among rabbits treated with albendazol and metronidazol respectively, which was significant at p<0.05 in comparision with the control group 500%, ( Table 2 ) . 
Discussion
All experimental mice used, showed no infection with E. histolytica. Several factors are involved in the successful infection with E. histolytica in rabbits. These include:
strain of E. histolytica (clinical isolate) used, age ,weight, , diet, and the most important factors are the strain and the susceptibility of the host to E. histolytica (8) . Other workers reported that the experimental infection of rats with E. histolytica (clinical strain) are all virulent to rats, whereas those isolated from carriers were either unable to produce ulcers or had low virulence as compared to strains of E. histolytica isolated from acute cases (9) . Our results indicate that the unsusceptiblety of mice and the type of strains of E. histolytica clinical isolate which were used, may explain the failure of mice to produce infection as is also indicated by other workers (9) . But in experimental rabbits the results showed that the percentage of trophozoites viability in control group was 
Conclusions
In conclusion, albendazole was the best drug with excellent (100%) effectiveness against E. histolytica in experimental rabbits as compared to metronidazole as a control.
